• Sumatriptan Beyond Migraine: Anti-Inflammatory Evidence

  2026-09-29

  Ala and colleagues synthesized evidence that sumatriptan, traditionally a 5-HT1 receptor agonist for acute migraine, also modulates inflammatory signaling, nitric oxide pathways, CGRP release, and tissue injury responses. The review provides a useful framework for serotonergic signaling research while emphasizing that most evidence remains preclinical and requires careful translational validation.

• Chlorogenic Acid–Metal Assemblies in Inflammation

  2026-09-29

  The reference study shows that combining chlorogenic acids with iron or copper can generate mainly 1:1 supramolecular assemblies with stronger anti-inflammatory activity than the parent compounds. Using RAW264.7 macrophages, the authors connect reduced NO and cytokine production to suppression of NF-κB signaling and lower iNOS and COX-2 expression, while also illustrating how chemical assembly can improve natural-product activity.

• Strategic ROS Sensing in Translational Oncology

  2026-09-28

  A mechanistic and strategic guide to using 2',7'-Dichlorofluorescein diacetate for intracellular ROS measurement, with practical assay guidance and translational lessons from ROS-responsive pancreatic cancer nanocarriers.

• Oleanolic Acid in Dual-Loaded Liposome Research

  2026-09-28

  Oleanolic acid is a research triterpenoid whose product description links inducible nitric oxide synthase induction and cyclooxygenase-2 modulation to anti-HIV research. A 2025 liposome-method study included oleanolic acid among tested co-loaded payloads and reported nanoparticle exclusion chromatography as a broadly applicable way to assess encapsulation efficiency—not as evidence of antiviral efficacy.

• CD36 Lipid Signaling Drives Immune Escape in AML

  2026-09-26

  A 2024 study identifies a CD36-dependent lipid-sensing pathway that helps acute myeloid leukemia cells suppress T-cell activity and resist decitabine treatment. Its findings distinguish CD36-mediated innate immune signaling from lipid oxidation and suggest that statin treatment can weaken this immunosuppressive program in preclinical models.

• Proteoform-Resolved Drug Binding in Native Membranes

  2026-09-25

  Lutomski and colleagues developed a native mass-spectrometry workflow that releases membrane proteins and signalling complexes directly from retina rod-disc membranes, preserving information about proteoforms and molecular interactions. Applying it to rhodopsin, G proteins and retinal PDE6, the study shows how protein modifications can shape complex assembly and drug interactions—an important consideration for interpreting selectivity and off-target pharmacology.

• CCK-8s Drives ANP Secretion in Rat Atria

  2026-09-25

  In isolated beating rat atria, sulfated cholecystokinin octapeptide (CCK-8s) promoted ANP secretion through a signaling sequence involving cPLA₂, NOX4, PGC-1α, and PPARα/PPARγ, while also reducing atrial contractile activity. The study connects redox signaling with cardiac hormone release and provides an ex vivo framework for investigating atrial responses; it does not test PPM-18 or NF-κB–iNOS signaling.

• PPARγ Activation Rebalances Macrophages in DSS Colitis

  2026-09-24

  A 2025 study tested whether PPARγ activation could shift macrophage polarization and reduce dextran sulfate sodium (DSS)-induced intestinal inflammation. Cell and mouse findings link reduced STAT-1 phosphorylation and increased STAT-6 phosphorylation with improved clinical, tissue, and barrier readouts, while leaving important questions about causality and clinical translation unresolved.

• L-NAME Hydrochloride: Assay Workflows & Uses

  2026-09-24

  Use L-NAME Hydrochloride to test whether nitric oxide synthase activity contributes to inflammatory readouts or vascular responses—not simply to lower a signal. This guide pairs practical dose-finding and controls with an anti-inflammatory study that measured nitric oxide, cytokines, iNOS, and COX-2.

• Pam3CSK4 Workflows for Innate and Neuro-Immune Studies

  2026-09-23

  Use Pam3CSK4 to create a defined TLR1/2 stimulus for macrophage and immune-cell activation assays, then compare that response with neural control of inflammation. Practical workflow guidance emphasizes dose finding, matched controls, and the limits of connecting these distinct experimental systems.

• Gastrin I (human): Assay Reliability Guide

  2026-09-23

  This scenario-based guide explains how Gastrin I (human), SKU B5358, can support controlled gastric acid secretion pathway research and receptor-mediated cell assays. It covers peptide handling, viability-assay interpretation, organoid-model limitations, protocol parameters, and practical vendor-selection criteria.

• 2',7'-Dichlorofluorescein Diacetate for ROS Assays

  2026-09-22

  Use 2',7'-Dichlorofluorescein diacetate for practical, quantitative intracellular ROS measurement across microscopy, flow cytometry, and plate-based workflows. This guide connects assay design with redox-responsive pancreatic cancer nanocarrier research while emphasizing controls, interpretation, and troubleshooting.

• Adiponectin Protects Cognition After Splenectomy

  2026-09-22

  The reference study used an aged-rat splenectomy model to show that adiponectin pretreatment improves postoperative cognitive performance while reducing hippocampal neuroinflammation and oxidative stress. Its antagonist–agonist design links these effects to suppression of the TLR4/MyD88/NF-κB pathway, while also highlighting important limits for clinical translation.

• Alda 1: From Aldehyde Stress to Cardiac Repair

  2026-09-21

  Alda 1 is an ALDH2 activator that connects mitochondrial aldehyde detoxification with cardiomyocyte proliferation. This article explains how to select cardiac models, separate enzyme-level effects from regenerative phenotypes, and interpret emerging evidence across ischemia, pressure overload, and radiation injury.

• 2',7'-Dichlorofluorescein diacetate for ROS Assays

  2026-09-21

  Turn a general redox signal into actionable data for cancer, toxicology, and drug-discovery experiments. This workflow shows how to use 2',7'-Dichlorofluorescein diacetate alongside nanocarrier studies without mistaking oxidative-stress fluorescence for species-specific proof.

8622 records 1/575 page Next 12345 下5页 Last page